159 related articles for article (PubMed ID: 8143220)
1. Sotalol in patients with implanted automatic defibrillators: effects on defibrillation and comparison with amiodarone.
Dorian P; Newman D; Harris L; Downar E
Can J Cardiol; 1994 Mar; 10(2):193-200. PubMed ID: 8143220
[TBL] [Abstract][Full Text] [Related]
2. Effect of amiodarone and sotalol on ventricular defibrillation threshold: the optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trial.
Hohnloser SH; Dorian P; Roberts R; Gent M; Israel CW; Fain E; Champagne J; Connolly SJ
Circulation; 2006 Jul; 114(2):104-9. PubMed ID: 16818810
[TBL] [Abstract][Full Text] [Related]
3. High defibrillation threshold at cardioverter defibrillator implantation under amiodarone treatment: favorable effects of D, L-sotalol.
Boriani G; Biffi M; Frabetti L; Maraschi M; Branzi A
Heart Lung; 2000; 29(6):412-6. PubMed ID: 11080321
[TBL] [Abstract][Full Text] [Related]
4. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
[TBL] [Abstract][Full Text] [Related]
5. Effect of concomitant antiarrhythmic therapy on survival in patients with implantable cardioverter defibrillators.
Ho AT; Pai SM; Timothy P; Pai RG
Pacing Clin Electrophysiol; 2005 Jul; 28(7):647-53. PubMed ID: 16008799
[TBL] [Abstract][Full Text] [Related]
6. Prospective clinical evaluation and follow-up of a cohort of consecutive VT/VF patients, using a staged-care protocol, including coronary arteriography, programmed electrical stimulation and cardiac surgery.
Naccarella F; Rolli A; Carboni A; Finardi A; Aurier E; Favaro L; Contini S; Gherli T; Caponi D; Maranga SS; Lepera G; Bartoletti A
G Ital Cardiol; 1999 Oct; 29(10):1142-56. PubMed ID: 10546124
[TBL] [Abstract][Full Text] [Related]
7. Effect of amiodarone and sotalol on the defibrillation threshold in comparison to patients without antiarrhythmic drug treatment.
Kühlkamp V; Mewis C; Suchalla R; Mermi J; Dörnberger V; Seipel L
Int J Cardiol; 1999 Jun; 69(3):271-9. PubMed ID: 10402110
[TBL] [Abstract][Full Text] [Related]
8. Effect of sotalol on ventricular fibrillation and defibrillation in humans.
Dorian P; Newman D
Am J Cardiol; 1993 Aug; 72(4):72A-79A. PubMed ID: 8346730
[TBL] [Abstract][Full Text] [Related]
9. Use of a combination of class III and class Ic antiarrhythmic agents in patients with electrical storm.
Fuchs T; Groysman R; Meilichov I
Pharmacotherapy; 2008 Jan; 28(1):14-9. PubMed ID: 18154469
[TBL] [Abstract][Full Text] [Related]
10. Effect of defibrillation testing on management during implantable cardioverter-defibrillator implantation.
Leong-Sit P; Gula LJ; Diamantouros P; Krahn AD; Skanes AC; Yee R; Klein GJ
Am Heart J; 2006 Dec; 152(6):1104-8. PubMed ID: 17161062
[TBL] [Abstract][Full Text] [Related]
11. The Midlands Trial of Empirical Amiodarone versus Electrophysiology-guided Interventions and Implantable Cardioverter-defibrillators (MAVERIC): a multi-centre prospective randomised clinical trial on the secondary prevention of sudden cardiac death.
Lau EW; Griffith MJ; Pathmanathan RK; Ng GA; Clune MM; Cooper J; Marshall HJ; Forsey PR; Stafford PJ; Gray RG; Skehan JD; Garratt CJ
Europace; 2004 Jul; 6(4):257-66. PubMed ID: 15172648
[TBL] [Abstract][Full Text] [Related]
12. Clinical predictors of defibrillation threshold in patients with implantable cardioverter-defibrillators.
Lubiński A; Lewicka-Nowak E; Zienciuk A; Królak T; Kempa M; Pazdyga A; Swiatecka G
Kardiol Pol; 2005 Apr; 62(4):317-28; discussion 329-31. PubMed ID: 15928737
[TBL] [Abstract][Full Text] [Related]
13. Implantable defibrillators and/or amiodarone: alternatives or complementary therapies.
Dorian P; Newman D; Greene M
Int J Clin Pract; 1998 Sep; 52(6):425-8. PubMed ID: 9894382
[TBL] [Abstract][Full Text] [Related]
14. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SPPAF), a randomized, placebo-controlled trial.
Auer J; Weber T; Berent R; Puschmann R; Hartl P; Ng CK; Schwarz C; Lehner E; Strasser U; Lassnig E; Lamm G; Eber B;
Am Heart J; 2004 Apr; 147(4):636-43. PubMed ID: 15077078
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of appropriate cardioverter-defibrillator shocks in 1038 consecutive patients with implantable cardioverter-defibrillators.
Kruger A; Aronow WS; Lai H; Desai H; Singla A; Frishman WH; Cohen M; Sorbera C
Am J Ther; 2009; 16(4):323-5. PubMed ID: 19617719
[TBL] [Abstract][Full Text] [Related]
16. d-Sotalol decreases defibrillation energy requirements in humans: a novel indication for drug therapy.
Dorian P; Newman D; Sheahan R; Tang A; Green M; Mitchell J
J Cardiovasc Electrophysiol; 1996 Oct; 7(10):952-61. PubMed ID: 8894937
[TBL] [Abstract][Full Text] [Related]
17. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
Wilkoff BL;
Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
[TBL] [Abstract][Full Text] [Related]
18. Comparison of ventricular arrhythmia burden, therapeutic interventions, and survival, in patients < 75 and patients >or= 75 years of age treated with implantable cardioverter defibrillators.
Ermis C; Zhu AX; Vanheel L; Sakaguchi RN; Lurie KG; Lu F; Benditt DG
Europace; 2007 May; 9(5):270-4. PubMed ID: 17371804
[TBL] [Abstract][Full Text] [Related]
19. [Role of antiarrhythmic drugs in reducing the number of defibrillation shocks].
Deharo JC; Mouliom F; Salamand A; Djiane P
Arch Mal Coeur Vaiss; 2005 Feb; 98(2):140-4. PubMed ID: 15787306
[TBL] [Abstract][Full Text] [Related]
20. [Short-term and long-term outcome of left heart function after cardioverter defibrillator implantation].
Takeichi K; Kasanuki H; Ohnishi S; Endoh Y; Hosoda S
J Cardiol; 1996 Nov; 28(5):277-86. PubMed ID: 8953401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
